Effect of Glyceryl Trinitrate on Hemodynamics in Acute Stroke

Background and Purpose— Increased blood pressure (BP), heart rate, and their derivatives (variability, pulse pressure, rate-pressure product) are associated with poor clinical outcome in acute stroke. We assessed the effects of glyceryl trinitrate (GTN) on hemodynamic parameters and these on outcome in participants in the ENOS trial (Efficacy of Nitric Oxide in Stroke). Methods— Four thousand and eleven patients with acute stroke and raised BP were randomized within 48 hours of onset to transdermal GTN or no GTN for 7 days. Peripheral hemodynamics were measured at baseline (3 measures) and daily (2 measures) during treatment. Between-visit BP variability over days 1 to 7 (as SD) was assessed in quintiles. Functional outcome was assessed as modified Rankin Scale and cognition as telephone mini-mental state examination at day 90. Analyses were adjusted for baseline prognostic variables. Data are mean difference or odds ratios with 95% CI. Results— Increased baseline BP (diastolic, variability), heart rate, and rate-pressure product were each associated with unfavorable functional outcome at day 90. Increased between-visit systolic BP variability was associated with an unfavourable shift in modified Rankin Scale (highest quintile adjusted odds ratio, 1.65; 95% CI, 1.37–1.99), worse cognitive scores (telephone mini-mental state examination: highest quintile adjusted mean difference, −2.03; 95% CI, −2.84 to −1.22), and increased odds of death at day 90 (highest quintile adjusted odds ratio, 1.57; 95% CI, 1.12–2.19). GTN lowered BP and rate-pressure product and increased heart rate at day 1 and reduced between-visit systolic BP variability. Conclusions— Increased between-visit BP variability was associated with poor functional and cognitive outcomes and increased death 90 days after acute stroke. In addition to lowering BP and rate-pressure product, GTN reduced between-visit systolic BP variability. Agents that lower BP variability in acute stroke require further study.

[1]  J. Chen,et al.  Effects of immediate blood pressure reduction on death and major disability in patients with acute ischemic stroke: the CATIS randomized clinical trial. , 2014, JAMA.

[2]  D. Leys,et al.  Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial , 2006, Journal of hypertension.

[3]  P. Bath,et al.  The Effect of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Blood Pressure and Platelet Function in Acute Stroke , 2001, Cerebrovascular Diseases.

[4]  P. Lazzerini,et al.  Increased Arterial Stiffness is Associated with Poor Collaterals in Acute Ischemic Stroke from Large Vessel Occlusion. , 2018, Current neurovascular research.

[5]  D. Jatužis,et al.  The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial , 2011, The Lancet.

[6]  P. Sandercock,et al.  Blood Pressure and Clinical Outcomes in the International Stroke Trial , 2002, Stroke.

[7]  J. Leonardi-Bee,et al.  High blood pressure in acute stroke and subsequent outcome: a systematic review. , 2004, Hypertension.

[8]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[9]  R. Conwit,et al.  Association Between Hyperacute Stage Blood Pressure Variability and Outcome in Patients With Spontaneous Intracerebral Hemorrhage , 2018, Stroke.

[10]  S. Pocock,et al.  Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial , 2014, International journal of stroke : official journal of the International Stroke Society.

[11]  P. Bath,et al.  Feasibility of an Ambulance-Based Stroke Trial, and Safety of Glyceryl Trinitrate in Ultra-Acute Stroke: The Rapid Intervention With Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824) , 2013, Stroke.

[12]  D. Leys,et al.  The Relationship Between Baseline Blood Pressure and Computed Tomography Findings in Acute Stroke: Data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) , 2009, Stroke.

[13]  D. Leys,et al.  Relationship Between Baseline Blood Pressure Parameters (Including Mean Pressure, Pulse Pressure, and Variability) and Early Outcome After Stroke: Data From the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST) , 2011, Stroke.

[14]  M. Dennis,et al.  Dehydration in Hospital-Admitted Stroke Patients: Detection, Frequency, and Association , 2012, Stroke.

[15]  J. Wardlaw,et al.  Transdermal Glyceryl Trinitrate Lowers Blood Pressure and Maintains Cerebral Blood Flow in Recent Stroke , 2006, Hypertension.

[16]  M. Woodward,et al.  Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. , 2013, The New England journal of medicine.

[17]  V. Hachinski,et al.  Complications of acute stroke , 1992, The Lancet.

[18]  P. Whincup,et al.  Cardiovascular risk profile and frailty in a population-based study of older British men , 2014, Heart.

[19]  S. Gosselin,et al.  Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. , 2018, CJEM.

[20]  P. Rothwell,et al.  Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis , 2010, The Lancet.

[21]  J. Staessen,et al.  Blood pressure as a prognostic factor after acute stroke , 2009, The Lancet Neurology.

[22]  M. Woodward,et al.  Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial , 2014, The Lancet Neurology.

[23]  J. Leonardi-Bee,et al.  The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. , 2003, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[24]  K. Toyoda,et al.  Effects of 24-Hour Blood Pressure and Heart Rate Recorded With Ambulatory Blood Pressure Monitoring on Recovery From Acute Ischemic Stroke , 2011, Stroke.

[25]  M. Niewada,et al.  Thrombolysis for Stroke in Poland: First 2 Years of Experience , 2006, International journal of stroke : official journal of the International Stroke Society.

[26]  E. T. Investigators.  Baseline characteristics of the 4011 patients recruited into the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial , 2014 .

[27]  P. Rothwell,et al.  Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke: Systematic Review , 2015, Stroke.

[28]  H. Milionis,et al.  Anemia on Admission Predicts Short- and Long-Term Outcomes in Patients with Acute Ischemic Stroke , 2015, International journal of stroke : official journal of the International Stroke Society.

[29]  E. T. Investigators,et al.  Glyceryl Trinitrate vs. Control, and Continuing vs. Stopping Temporarily Prior Antihypertensive Therapy, in Acute Stroke: Rationale and Design of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial (ISRCTN99414122) , 2006, International journal of stroke : official journal of the International Stroke Society.

[30]  P. Bath,et al.  Therapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke , 2016, CNS Drugs.

[31]  Jiguang Wang,et al.  Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial Studies , 2016, Stroke.

[32]  P. Sandercock,et al.  Effects of Blood Pressure and Blood Pressure–Lowering Treatment During the First 24 Hours Among Patients in the Third International Stroke Trial of Thrombolytic Treatment for Acute Ischemic Stroke , 2015, Stroke.

[33]  P. Lazzerini,et al.  Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis. , 2017, International journal of cardiology.

[34]  Jo Leonardi-Bee,et al.  High Blood Pressure in Acute Stroke and Subsequent Outcome: A Systematic Review , 2004 .

[35]  F. Mee,et al.  Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. , 1996, Blood pressure monitoring.

[36]  Myzoon Ali,et al.  Relationship Between Hyperacute Blood Pressure and Outcome After Ischemic Stroke: Data From the VISTA Collaboration , 2009, Stroke.

[37]  P. Bath.  Baseline Characteristics of the 4011 Patients Recruited into the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) Trial , 2014 .

[38]  H. Diener,et al.  Impact of heart rate on admission on mortality and morbidity in acute ischaemic stroke patients – results from VISTA , 2016, European journal of neurology.

[39]  M. Edwards,et al.  Trial , 2004, The Lancet.

[40]  J. Wardlaw,et al.  Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial , 2015, Stroke.

[41]  Eoin O'Brien,et al.  Effects of β blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke , 2010, The Lancet Neurology.

[42]  M. Woodward,et al.  Blood pressure variability and outcome after acute intracerebral haemorrhage : a post-hoc analysis of INTERACT 2 , a randomised controlled trial * , 2014 .

[43]  S. Pocock,et al.  Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053) , 2019, International journal of stroke : official journal of the International Stroke Society.

[44]  D. Hanley,et al.  Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. , 2016, The New England journal of medicine.

[45]  G. Tsivgoulis,et al.  U‐shaped relationship between mortality and admission blood pressure in patients with acute stroke , 2004, Journal of internal medicine.

[46]  E. T. Investigators,et al.  Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial , 2015, The Lancet.